+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Women`s Healthcare - Global Strategic Business Report

  • PDF Icon

    Report

  • 189 Pages
  • July 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6107190
The global market for Women`s Healthcare was estimated at US$9.7 Billion in 2024 and is projected to reach US$12.1 Billion by 2030, growing at a CAGR of 3.8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Women`s Healthcare market.

Global Women's Healthcare Market - Key Trends & Drivers Summarized

Why Is Women's Healthcare Emerging as a Distinct and Prioritized Sector in Global Health?

Women's healthcare is rapidly evolving as a specialized domain within the broader healthcare ecosystem, reflecting the growing awareness that women have unique physiological, hormonal, and reproductive health needs across different life stages. Unlike traditional healthcare models that often generalized treatments for both genders, modern medicine increasingly recognizes the importance of gender-specific diagnostics, treatments, and preventive care. The prioritization of women's health stems from a history of underrepresentation in clinical research and systemic neglect, which has led to misdiagnoses and suboptimal care for female patients. Today, governments, healthcare providers, and global organizations are placing a stronger emphasis on addressing these disparities by tailoring services that focus on menstrual health, fertility, pregnancy, menopause, breast and gynecological cancers, osteoporosis, and autoimmune diseases, among others. Social movements and advocacy efforts have brought attention to issues like endometriosis, postpartum depression, and contraceptive access, prompting better policy responses and funding allocation. In addition, an aging female population worldwide is increasing demand for chronic disease management related to cardiovascular health, bone density, and hormone regulation. By recognizing that women's healthcare needs extend far beyond reproductive care, the medical community is taking steps to develop a more comprehensive and equitable system that ensures timely, accurate, and gender-sensitive care for women of all ages and backgrounds.

How Are Technological Innovations Revolutionizing the Women's Healthcare Landscape?

Technology is playing a transformative role in reshaping the women's healthcare landscape, making care more personalized, accessible, and data-driven. One of the most impactful developments is the proliferation of digital health tools such as mobile apps, wearable devices, and telehealth platforms that enable women to track their menstrual cycles, monitor pregnancy progress, access contraception advice, and manage chronic conditions from the comfort of their homes. Fertility tech, including ovulation trackers and AI-assisted in vitro fertilization (IVF) platforms, is empowering women with more control over their reproductive timelines. Diagnostic technologies have also improved, enabling earlier detection of diseases such as breast and ovarian cancer through advanced imaging and genetic testing. Remote consultations have become especially important in rural and underserved areas, where women often face barriers related to mobility, stigma, or lack of nearby specialists. In addition, electronic health records and predictive analytics are helping clinicians tailor treatment plans based on individual patient profiles, improving outcomes in areas like hormonal therapy and prenatal care. Startups and femtech companies are leading the charge by developing innovative solutions such as non-invasive diagnostics, digital pelvic floor trainers, and mental health platforms that cater specifically to women's unique needs. These innovations are not only enhancing clinical care but also breaking down longstanding taboos and promoting a culture of health empowerment, allowing women to take an active role in their well-being with unprecedented ease and confidence.

What Societal Shifts and Policy Changes Are Influencing the Women's Healthcare Market?

Societal awareness and policy reforms are playing an increasingly important role in shaping the direction and momentum of the women's healthcare market. Around the world, women are demanding better access to quality healthcare, equal representation in clinical research, and stronger protections against health inequities, leading to more robust public discourse and legislative action. Governments and health agencies are enacting policies to expand coverage for maternal care, fertility treatments, contraception, and cancer screenings, often under broader gender equality or universal healthcare frameworks. The global conversation around menstrual equity is prompting institutions to provide free sanitary products and education, helping dismantle the stigma that surrounds menstruation. Additionally, the rising visibility of women's mental health challenges, including postpartum depression and anxiety disorders, is prompting a shift toward more inclusive and integrated mental healthcare services. Insurance providers are also beginning to include more comprehensive women's health benefits, reflecting market demand for better preventive care and long-term wellness solutions. Media and advocacy campaigns continue to amplify the voices of those affected by chronic yet underdiagnosed conditions such as polycystic ovary syndrome (PCOS), fibroids, and perimenopause symptoms, prompting the medical community to invest in research and education. These societal and regulatory shifts are not only improving access to care but also reshaping cultural narratives around female health, affirming that women's medical concerns are both valid and deserving of systemic support. The result is a more informed, engaged, and empowered patient base that expects healthcare systems to evolve in step with their needs.

What Is Driving the Global Growth and Long-Term Potential of the Women's Healthcare Market?

The growth in the women's healthcare market is driven by a confluence of demographic, technological, economic, and sociopolitical factors that together underscore the importance and urgency of investing in gender-specific health solutions. One of the primary drivers is the rising global female population coupled with increased life expectancy, which is resulting in higher demand for long-term care related to aging, hormonal changes, and chronic illness management. Economic empowerment and higher educational attainment among women are also contributing to a more health-literate consumer base that actively seeks preventive care and personalized treatment options. The increasing availability and affordability of health technologies, from fertility diagnostics to telemedicine platforms, are expanding access and enabling earlier interventions, particularly in emerging economies where healthcare infrastructure is improving rapidly. Venture capital investment in femtech and women-centric health startups is infusing the market with innovation and helping address historically neglected areas. In parallel, multinational pharmaceutical companies are launching new therapeutics tailored to conditions affecting women, from hormone therapies to targeted cancer treatments. Regulatory bodies are responding by streamlining approval pathways for female-specific drugs and devices, further accelerating market development. Corporate wellness programs and workplace health initiatives are also beginning to recognize and address women's unique health challenges, fostering better health outcomes and productivity. These interconnected drivers reflect a sustained commitment to closing the gender gap in healthcare, ensuring that women receive the attention, research, and medical advancements long overdue. The trajectory of the women's healthcare market points toward continued global expansion, supported by a growing awareness that empowering women's health is foundational to the well-being of families, communities, and economies.

Scope Of Study:

The report analyzes the Women`s Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments: Application (Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application, Other Applications)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Hormonal Infertility Application segment, which is expected to reach US$3.1 Billion by 2030 with a CAGR of a 3.4%. The Postmenopausal Osteoporosis Application segment is also set to grow at 2.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $2.6 Billion in 2024, and China, forecasted to grow at an impressive 6.8% CAGR to reach $2.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Women`s Healthcare Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Women`s Healthcare Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Women`s Healthcare Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as AbbVie, Astellas Pharma, AstraZeneca, Ava Women, Besins Healthcare and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 36 companies featured in this Women`s Healthcare market report include:

  • AbbVie
  • Astellas Pharma
  • AstraZeneca
  • Ava Women
  • Besins Healthcare
  • Bonzun
  • Duchesnay
  • Flo Health
  • Lilly (Eli Lilly)
  • Mayne Pharma
  • Medicines360
  • Midi Health
  • Morgan Stanley Inclusive Lab
  • Natural Cycles
  • Organon
  • Pfizer
  • Pristyn Care
  • Roche
  • Ru Medical (Unpause)
  • Sanofi

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Women`s Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Awareness of Gender-Specific Health Needs Throws the Spotlight on Women`s Healthcare as a Global Priority
  • Shift Toward Preventive Care Models Spurs Demand for Early Diagnosis and Screening Services Across Female Health Conditions
  • Here`s How Digital Health Platforms Are Expanding Access to Reproductive and Menstrual Health Management
  • Increased Focus on Maternal Health and Safe Childbirth Strengthens the Business Case for Integrated Prenatal Care Solutions
  • Investment in Fertility Services and Egg Freezing Expands the Addressable Market Opportunity in Reproductive Technologies
  • Aging Female Population and Menopause Management Drive Innovation in Hormone Therapy and Lifestyle Interventions
  • Rising Mental Health Awareness Among Women Fuels Demand for Gender-Sensitive Therapy and Support Programs
  • Here`s How FemTech Startups Are Disrupting Traditional Care Models with Personalized, App-Based Solutions
  • Growth in Gynecological Oncology Screening and Treatment Accelerates Adoption of Advanced Diagnostics and Surgical Tools
  • Workplace Wellness Programs and Corporate Benefits Support Expansion of Holistic Women-Centered Care Offerings
  • Access to Contraceptive Options and Family Planning Services Sustains Progress in Reproductive Autonomy and Choice
  • Global Rise in Polycystic Ovary Syndrome (PCOS), Endometriosis, and Autoimmune Disorders Highlights Unmet Needs in Women`s Health
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Women`s Healthcare Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Women`s Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Women`s Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Women`s Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Hormonal Infertility Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Hormonal Infertility Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Hormonal Infertility Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Postmenopausal Osteoporosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Postmenopausal Osteoporosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Postmenopausal Osteoporosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Endometriosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Endometriosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Endometriosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Contraceptives Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Contraceptives Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Contraceptives Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Menopause Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Menopause Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Menopause Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Polycystic Ovary Syndrome Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Polycystic Ovary Syndrome Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Polycystic Ovary Syndrome Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Women`s Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Women`s Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Women`s Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
JAPAN
  • Women`s Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 32: Japan Recent Past, Current & Future Analysis for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Japan Historic Review for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: Japan 16-Year Perspective for Women`s Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
CHINA
  • Women`s Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 35: China Recent Past, Current & Future Analysis for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: China Historic Review for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: China 16-Year Perspective for Women`s Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
EUROPE
  • Women`s Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 38: Europe Recent Past, Current & Future Analysis for Women`s Healthcare by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: Europe Historic Review for Women`s Healthcare by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: Europe 16-Year Perspective for Women`s Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 41: Europe Recent Past, Current & Future Analysis for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Europe Historic Review for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: Europe 16-Year Perspective for Women`s Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
FRANCE
  • Women`s Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 44: France Recent Past, Current & Future Analysis for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: France Historic Review for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: France 16-Year Perspective for Women`s Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
GERMANY
  • Women`s Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 47: Germany Recent Past, Current & Future Analysis for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Germany Historic Review for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: Germany 16-Year Perspective for Women`s Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
ITALY
  • TABLE 50: Italy Recent Past, Current & Future Analysis for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Italy Historic Review for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Italy 16-Year Perspective for Women`s Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
UNITED KINGDOM
  • Women`s Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 53: UK Recent Past, Current & Future Analysis for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: UK Historic Review for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: UK 16-Year Perspective for Women`s Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
SPAIN
  • TABLE 56: Spain Recent Past, Current & Future Analysis for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Spain Historic Review for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Spain 16-Year Perspective for Women`s Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
RUSSIA
  • TABLE 59: Russia Recent Past, Current & Future Analysis for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Russia Historic Review for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Russia 16-Year Perspective for Women`s Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
REST OF EUROPE
  • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Rest of Europe Historic Review for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Rest of Europe 16-Year Perspective for Women`s Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
ASIA-PACIFIC
  • Women`s Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 65: Asia-Pacific Recent Past, Current & Future Analysis for Women`s Healthcare by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: Asia-Pacific Historic Review for Women`s Healthcare by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Asia-Pacific 16-Year Perspective for Women`s Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 68: Asia-Pacific Recent Past, Current & Future Analysis for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Asia-Pacific Historic Review for Women`s Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Asia-Pacific 16-Year Perspective for Women`s Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
AUSTRALIA
  • Women`s Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Women`s Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Women`s Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Women`s Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Women`s Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie
  • Astellas Pharma
  • AstraZeneca
  • Ava Women
  • Besins Healthcare
  • Bonzun
  • Duchesnay
  • Flo Health
  • Lilly (Eli Lilly)
  • Mayne Pharma
  • Medicines360
  • Midi Health
  • Morgan Stanley Inclusive Lab
  • Natural Cycles
  • Organon
  • Pfizer
  • Pristyn Care
  • Roche
  • Ru Medical (Unpause)
  • Sanofi

Table Information